These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 11560069)

  • 41. Implications of pharmacogenomics for drug development.
    Kirk RJ; Hung JL; Horner SR; Perez JT
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug screening--beyond the bottleneck.
    Dove A
    Nat Biotechnol; 1999 Sep; 17(9):859-63. PubMed ID: 10471925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A hierarchical screening methodology for physicochemical/ADME/Tox profiling.
    DeWitte RS; Robins RH
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):805-17. PubMed ID: 17014396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Recent trends in the standardization of laboratory automation].
    Tao R; Yamashita K
    Rinsho Byori; 2000 Oct; (Suppl 114):51-8. PubMed ID: 11215175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combinatorial Heterogeneous Catalysis-A New Path in an Old Field.
    Senkan S
    Angew Chem Int Ed Engl; 2001 Jan; 40(2):312-329. PubMed ID: 11180318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-throughput screening. Advances in robotics and miniturization continue to accelerate drug lead identification.
    Persidis A
    Nat Biotechnol; 1998 May; 16(5):488-9. PubMed ID: 9592401
    [No Abstract]   [Full Text] [Related]  

  • 47. The innovative crisis as a current pharmaceutical research problem: causes, consequences, responses and solutions.
    Bucurescu S
    Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):305-9. PubMed ID: 22530345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ADME-Tox in drug discovery: integration of experimental and computational technologies.
    Yu H; Adedoyin A
    Drug Discov Today; 2003 Sep; 8(18):852-61. PubMed ID: 12963322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The organization of a research laboratory in pharmaceutical industry].
    Fishburn AG
    Ann Pharm Fr; 1970 Feb; 28(2):93-8. PubMed ID: 5429058
    [No Abstract]   [Full Text] [Related]  

  • 50. Workflow analysis, a tool for laboratorians. Case study: a drug-testing laboratory.
    Lehmann C; Leiken A; Branchflower R
    Am Clin Lab; 1994 May; 13(5):12-3. PubMed ID: 10147161
    [No Abstract]   [Full Text] [Related]  

  • 51. Lessons from the Fersht laboratory could be vital for the future of the pharmaceutical industry.
    Ward WH
    Protein Eng Des Sel; 2011 Jan; 24(1-2):65-7. PubMed ID: 20876191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inventory management and reagent supply for automated chemistry.
    Kuzniar E
    Comb Chem High Throughput Screen; 1999 Aug; 2(4):239-47. PubMed ID: 10469883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laboratory automation of high-quality and efficient ligand-binding assays for biotherapeutic drug development.
    Wang J; Patel V; Burns D; Laycock J; Pandya K; Tsoi J; DeSilva B; Ma M; Lee J
    Bioanalysis; 2013 Jul; 5(13):1635-48. PubMed ID: 23822127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrity and efficiency: AbbVie's journey of building an integrated nonregulated bioanalytical laboratory.
    Wang YT; Maes EM; Heinle L; Ruterbories K; Doktor S; Larsen M; Olson A; Lee A; Van Handel C; Ji QC; Desino K; Jenkins GJ
    Bioanalysis; 2023 Feb; 15(3):161-176. PubMed ID: 36961367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Automating preanalytics: total laboratory automation, preanalytical line, or task targeted?
    Stauffer J; Pearlman ES; Bilello L
    Am Clin Lab; 2000 Aug; 19(7):22. PubMed ID: 11317417
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmaceutical process chemistry: evolution of a contemporary data-rich laboratory environment.
    Caron S; Thomson NM
    J Org Chem; 2015 Mar; 80(6):2943-58. PubMed ID: 25635809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Research in the pharmaceutical industry. Matrix organization of research and development laboratories].
    Mascellani G
    Farmaco Prat; 1984 Feb; 39(2):47-56. PubMed ID: 6714391
    [No Abstract]   [Full Text] [Related]  

  • 58. [From automation to robotics].
    Ann Biol Clin (Paris); 1985; 43(4):395-6. PubMed ID: 4091303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Social aspects of modern pharmacology].
    Zakusov VV
    Farmakol Toksikol; 1983; 46(3):5-12. PubMed ID: 6345191
    [No Abstract]   [Full Text] [Related]  

  • 60. Blood dyscrasias and the pharmaceutical industry: screening surveillance and monitoring, and future drug development.
    Eur J Haematol Suppl; 1996; 60():128-9. PubMed ID: 8987256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.